Report #2835390

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Feb 1, 2025
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Herpes zoster

Symptom narrative

got a small outbreak two weeks later; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis. In FEB-2025, the patient received Shingrix. On an unknown date, more than 2 weeks after receiving Shingrix, the patient experienced shingles (Verbatim: got a small outbreak two weeks later). The outcome of the shingles was not reported. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 02-APR-2025 This case was reported by a patient via (Shingrix chatbot) interactive digital media. The patient had the shingles vaccination in February 2025, a month ago. The patient got a small outbreak two weeks later.